In Brief: Endosonics
This article was originally published in The Gray Sheet
Executive Summary
Endosonics: Gains FDA approval for its Oracle Megasonics family of combined percutaneous transluminal coronary angioplasty and ultrasound imaging catheters. Intended for use with Cordis' Duralyn high-pressure PTCA balloon, the Megasonics catheter line "demonstrates the strategic advantages of an all-electronic design compared with competitive mechanical approaches (ultrasound transducer on a spinning drive shaft) because it can both provide images of the lumen and artery wall as well as perform PTCA," Endosonics says. The catheter system will be marketed in the U.S., Canada and Europe through Cordis, which has a marketing and joint technology development deal with Endosonics...